2022
DOI: 10.3390/ijms23116296
|View full text |Cite
|
Sign up to set email alerts
|

Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance

Abstract: Notch signaling dysregulation encourages breast cancer progression through different mechanisms such as stem cell maintenance, cell proliferation and migration/invasion. Furthermore, Notch is a crucial driver regulating juxtracrine and paracrine communications between tumor and stroma. The complex interplay between the abnormal Notch pathway orchestrating the activation of other signals and cellular heterogeneity contribute towards remodeling of the tumor microenvironment. These changes, together with tumor ev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 140 publications
0
10
0
Order By: Relevance
“…It has been discovered that Notch-3 NICD is abundantly expressed in breast tissue and is linked to the prevalence of mammary gland tumors, revealing its potential as an oncogene. Several breast gland cell lines associated with breast cancer have also been shown to express Notch-1 and Notch-3 NICD, supporting the idea of their involvement in breast tumorigenesis 142 . Dysfunctional genetic variants of Notch-4 NICD have been linked to breast tumorigenesis as well.…”
Section: Clinical Investigation Into Notch Signalling Expressionmentioning
confidence: 60%
“…It has been discovered that Notch-3 NICD is abundantly expressed in breast tissue and is linked to the prevalence of mammary gland tumors, revealing its potential as an oncogene. Several breast gland cell lines associated with breast cancer have also been shown to express Notch-1 and Notch-3 NICD, supporting the idea of their involvement in breast tumorigenesis 142 . Dysfunctional genetic variants of Notch-4 NICD have been linked to breast tumorigenesis as well.…”
Section: Clinical Investigation Into Notch Signalling Expressionmentioning
confidence: 60%
“…In the cell–cell interactions analysis, we found JAG-NOTCH interactions between tumor cells and endothelial cells. The Notch pathway is involved in tumor progression through various mechanisms such as stem cell maintenance, cell proliferation, and migration/invasion [ 51 , 52 ]. These studies reported that the Notch pathway regulates many components of the TME, including immune cells, fibroblast, endothelial, and mesenchymal cells.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have shown that Notch pathway activation is a major participant in breast cancer progression (23), therapy resistance (24) and is the pathognomonic feature in triple negative breast cancer (TNBC) (25). Notch1 has a role in maintaining CSC stemness in TNBC, and inhibiting this signal not only has an inhibitory effect on this cancer subtype but also increases its chemosensitivity (26).…”
Section: Discussionmentioning
confidence: 99%